Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's disease

被引:31
作者
Meier, A
Mollenhauer, B
Cohrs, S
Rodenbeck, A
Jordan, W
Meller, J
Otto, M
机构
[1] Univ Gottingen, Dept Psychiat & Psychotherapy, Sleep Disorders Ctr, D-37075 Gottingen, Germany
[2] Univ Gottingen, Dept Neurol, D-3400 Gottingen, Germany
[3] Univ Gottingen, Dept Nucl Med, D-3400 Gottingen, Germany
关键词
hypocretin; Huntington; orexin;
D O I
10.1016/j.brainres.2005.09.028
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A significant atrophy and loss of hypocretin neurons in the brains of human patients with Huntington's disease (HD) and in R6/2 mice have been reported. We included 10 patients with HD and 12 patients with chorea-like hyperkinetic movement disorders (non-HD). All patients of the HD group and eleven patients of the non-HD group showed normal hypocretin-1 levels. Thus, hypocretin-1 may not serve as an additional diagnostic marker for HD. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:201 / 203
页数:3
相关论文
共 12 条
  • [1] CSF hypocretin (Orexin) in neurological and psychiatric conditions
    Ebrahim, IO
    Semra, YK
    De Lacy, S
    Howard, RS
    Kopelman, MD
    Williams, A
    Sharief, MK
    [J]. JOURNAL OF SLEEP RESEARCH, 2003, 12 (01) : 83 - 84
  • [2] Huntington's disease:: pathomechanism and therapeutic perspectives
    Gárdián, G
    Vécsei, L
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2004, 111 (10-11) : 1485 - 1494
  • [3] CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia
    Kanbayashi, T
    Inoue, Y
    Chiba, S
    Aizawa, R
    Saito, Y
    Tsukamoto, H
    Fujii, Y
    Nishino, S
    Shimizu, T
    [J]. JOURNAL OF SLEEP RESEARCH, 2002, 11 (01) : 91 - 93
  • [4] A NOVEL GENE CONTAINING A TRINUCLEOTIDE REPEAT THAT IS EXPANDED AND UNSTABLE ON HUNTINGTONS-DISEASE CHROMOSOMES
    MACDONALD, ME
    AMBROSE, CM
    DUYAO, MP
    MYERS, RH
    LIN, C
    SRINIDHI, L
    BARNES, G
    TAYLOR, SA
    JAMES, M
    GROOT, N
    MACFARLANE, H
    JENKINS, B
    ANDERSON, MA
    WEXLER, NS
    GUSELLA, JF
    BATES, GP
    BAXENDALE, S
    HUMMERICH, H
    KIRBY, S
    NORTH, M
    YOUNGMAN, S
    MOTT, R
    ZEHETNER, G
    SEDLACEK, Z
    POUSTKA, A
    FRISCHAUF, AM
    LEHRACH, H
    BUCKLER, AJ
    CHURCH, D
    DOUCETTESTAMM, L
    ODONOVAN, MC
    RIBARAMIREZ, L
    SHAH, M
    STANTON, VP
    STROBEL, SA
    DRATHS, KM
    WALES, JL
    DERVAN, P
    HOUSMAN, DE
    ALTHERR, M
    SHIANG, R
    THOMPSON, L
    FIELDER, T
    WASMUTH, JJ
    TAGLE, D
    VALDES, J
    ELMER, L
    ALLARD, M
    CASTILLA, L
    SWAROOP, M
    [J]. CELL, 1993, 72 (06) : 971 - 983
  • [5] The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias
    Mignot, E
    Lammers, GJ
    Ripley, B
    Okun, M
    Nevsimalova, S
    Overeem, S
    Vankova, J
    Black, J
    Harsh, J
    Bassetti, C
    Schrader, H
    Nishino, S
    [J]. ARCHIVES OF NEUROLOGY, 2002, 59 (10) : 1553 - 1562
  • [6] Orexin loss in Huntington's disease
    Petersén, Å
    Gil, J
    Björkqvist, M
    Tanila, H
    Araújo, IM
    Smith, R
    Popovic, N
    Wierup, N
    Norlén, P
    Li, JY
    Roos, RAC
    Sundler, F
    Mulder, H
    Brundin, P
    [J]. HUMAN MOLECULAR GENETICS, 2005, 14 (01) : 39 - 47
  • [7] Sleep and quantitative EEG in neurodegenerative disorders
    Petit, D
    Gagnon, JF
    Fantini, ML
    Ferini-Strambi, L
    Montplaisir, J
    [J]. JOURNAL OF PSYCHOSOMATIC RESEARCH, 2004, 56 (05) : 487 - 496
  • [8] Peyron C, 1998, J NEUROSCI, V18, P9996
  • [9] CSF hypocretin/orexin levels in narcolepsy and other neurological conditions
    Ripley, B
    Overeem, S
    Fujiki, N
    Nevsimalova, S
    Uchino, M
    Yesavage, J
    Di Monte, D
    Dohi, K
    Melberg, A
    Lammers, GJ
    Nishida, Y
    Roelandse, FWC
    Hungs, M
    Mignot, E
    Nishino, S
    [J]. NEUROLOGY, 2001, 57 (12) : 2253 - 2258
  • [10] Sutcliffe JG, 2000, J NEUROSCI RES, V62, P161, DOI 10.1002/1097-4547(20001015)62:2<161::AID-JNR1>3.0.CO